Skip to main content
Premium Trial:

Request an Annual Quote

Illumina, Cornell Dismiss Patent Dispute

NEW YORK (GenomeWeb) – Illumina and Cornell University have jointly agreed to dismiss a patent dispute that originated in 2010, according to documents filed with the US District Court for the District of Delaware.

Cornell and Life Technologies (now part of Thermo Fisher Scientific) sued Illumina in May 2010, claiming that Illumina's microarray products infringed on eight patents held by Cornell and exclusively licensed to Life Tech.

The patents related to claims on detecting nucleic acid sequences using coupled ligase detection and PCR. In May 2016, the court issued recommendations for claims reconstruction, and then partly adopted and partly rejected those recommendations in January, following comments by both parties.  

This week, both parties sought to have those prior rulings withdrawn. Cornell and Life Technologies agreed to dismiss their claims against Illumina "with prejudice," and Illumina agreed to dismiss its counterclaims "without prejudice." Each party also agreed to cover its own legal costs. The court subsequently vacated its prior claims reconstruction recommendation and order.